12 results
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
disease (COPD) ... squared; CAT, COPD ... corticosteroid; LABA ... #COPD #Treatment ... #Pulmonary #LABA
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Obstructive Lung Disease ... LAMA: long-acting ... #Management #Pulmonary ... #COPD #GOLD2017 ... #LAMA #LABA #ICS
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
to respiratory risk ... ACO = asthma-COPD ... corticosteroids; LABA ... long-acting β2-agonist; LAMA ... #Diagnosis #Management
Chronic Obstructive Pulmonary Disease (COPD)
 • COPD Definition
 • Role of PFTs
 • COPD Classification and
Disease (COPD) ... post-bronchodilator FEV1 ... #Disease #COPD ... #diagnosis #management ... #GOLD2022 #treatment
Multifocal Atrial Tachycardia (MAT)
• At least 3 different P wave morphologies: 
• Rate 100-180
• Irregular 
Etiology
to chronic lung disease ... (COPD) • Hypoxia ... • Pulmonary hypertension ... • Oxygen • Treatment ... MAT #Cardiology #Diagnosis
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... days before Pulmonary ... Determine if any labs ... medical and surgical management ... stratification #diagnosis
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
MUCORMYCOSIS • Risk ... : • Labs nonspecific ... extrapulmonary disease ... Encapsulated yeast • At risk ... #Management #Infections
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Differential Diagnosis ... Valvular heart disease ... cardiomyopathy • Pulmonary ... teratogenic GDMT meds ... #treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Ocular examination Labs ... effusion, INC risk ... Malignancy Risk ... Adenocarcinoma Treatment ... #Management
Cryptogenic Organizing Pneumonia - Illness Script

PATHOPHYSIOLOGY: Unknown trigger, reversible inflammatory/fibroproliferative process. Polypoid fibroblastic aggregates that plug
identified (autoimmune, meds ... , neoplastic) TREATMENT ... steroids for severe disease ... TylerLarsenMD #COP ... #management #pulmonary